How reliable is the Ki‐67 cytological index in grading pancreatic neuroendocrine tumors? A meta‐analysis

E-ISSN： 1751-2980|17|2|95-103

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.17, Iss.2, 2016-02, pp. : 95-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus for the treatment of pancreatic neuroendocrine tumors

By Feldmann Georg Bisht Savita Schütte Ute Haarmann Jens Brossart Peter

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2073-2084

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic neuroendocrine tumors in twelve baboons (Papio spp.)

JOURNAL OF MEDICAL PRIMATOLOGY, Vol. 45, Iss. 2, 2016-04 ,pp. : 85-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

By Bisht Savita Feldmann Georg Brossart Peter

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 7, 2009-07 ,pp. : 712-712

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Meta-Analysis of Randomised Trials Comparing Gemcitabine-Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer

By Banu Eugeniu

Drugs & Aging, Vol. 24, Iss. 10, 2007-01 ,pp. : 865-879

Adis International

Access to resources Recommend Favorite